Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Krystal Biotech stock

Learn how to easily invest in Krystal Biotech stock.

Krystal Biotech Inc is a biotechnology business based in the US. Krystal Biotech shares (KRYS) are listed on the NASDAQ and all prices are listed in US Dollars. Krystal Biotech employs 75 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Krystal Biotech

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – KRYS – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Krystal Biotech stock price (NASDAQ: KRYS)

Use our graph to track the performance of KRYS stocks over time.

Krystal Biotech shares at a glance

Information last updated 2022-01-24.
Latest market close$57.06
52-week range$38.86 - $102.99
50-day moving average $63.30
200-day moving average $62.06
Wall St. target price$126.86
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-2.72

Buy Krystal Biotech shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
M1 Finance
Free 1-year trial of M1 Plus
when you sign up for M1 Finance
Invest in your favorite stocks or in curated portfolios with automatic rebalancing.
SoFi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in most equities.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$10 of crypto
Open an account with access to crypto
A platform built for all kinds of traders and all styles of trading
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stash Invest
Stocks, ETFs
$1 per month
Add at least $5 to your Invest account
Stash is more than an investment app. You’ll have access to tools that can help you become a confident investor.
Stocks, ETFs, Cryptocurrency
$0 per month
Download and sign up with; approved accounts receive a free stock slice worth up to $300, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Krystal Biotech stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Krystal Biotech price performance over time

Historical closes compared with the close of $57.06 from 2022-01-24

1 week (2022-01-18) -3.94%
1 month (2021-12-22) N/A
3 months (2021-10-26) 4.81%
6 months (2021-07-26) -0.56%
1 year (2021-01-26) -19.83%
2 years (2020-01-24) 1.86%
3 years (2019-01-25) 146.27%
5 years (2017-01-22) N/A

Krystal Biotech financials

Gross profit TTM $0
Return on assets TTM -9.31%
Return on equity TTM -16.38%
Profit margin 0%
Book value $18.36
Market capitalisation $1.4 billion

TTM: trailing 12 months

Krystal Biotech share dividends

We're not expecting Krystal Biotech to pay a dividend over the next 12 months.

Krystal Biotech share price volatility

Over the last 12 months, Krystal Biotech's shares have ranged in value from as little as $38.856 up to $102.99. A popular way to gauge a stock's volatility is its "beta".

KRYS.US volatility(beta: 0.91)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Krystal Biotech's is 0.9062. This would suggest that Krystal Biotech's shares are less volatile than average (for this exchange).

Krystal Biotech overview

Krystal Biotech, Inc. , a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing KB105 that is in Phase I/II clinical study for treating patients with deficient autosomal recessive congenital ichthyosis; KB301, which is in Phase I/II clinical stage for treating wrinkles and acne scars; KB407 that is in preclinical stage for cystic fibrosis; and KB104, which is in preclinical stage for netherton syndrome. Its discovery stage product candidates include KB5xx for treating chronic skin diseases, KB3xx to treat aesthetic skin conditions, and KB3xx for other rare lung disease. Krystal Biotech, Inc. was founded in 2015 and is headquartered in Pittsburgh, Pennsylvania.

Frequently asked questions

What percentage of Krystal Biotech is owned by insiders or institutions?
Currently 21.927% of Krystal Biotech shares are held by insiders and 70.33% by institutions.
How many people work for Krystal Biotech?
Latest data suggests 75 work at Krystal Biotech.
When does the fiscal year end for Krystal Biotech?
Krystal Biotech's fiscal year ends in December.
Where is Krystal Biotech based?
Krystal Biotech's address is: 2100 Wharton Street, Pittsburgh, PA, United States, 15203
What is Krystal Biotech's ISIN number?
Krystal Biotech's international securities identification number is: US5011471027
What is Krystal Biotech's CUSIP number?
Krystal Biotech's Committee on Uniform Securities Identification Procedures number is: 501147102

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site